Importance of CD117 in the evaluation of acute leukemias by flow cytometry

被引:16
|
作者
Newell, JO
Cessna, MH
Greenwood, J
Hartung, L
Bahler, DW [1 ]
机构
[1] Univ Utah, Med Ctr, Dept Pathol, Salt Lake City, UT 84132 USA
[2] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT USA
来源
CYTOMETRY PART B-CLINICAL CYTOMETRY | 2003年 / 52B卷 / 01期
关键词
CD117; flow cytometry; acute leukemia;
D O I
10.1002/cyto.b.10009
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background. The issue of which specific antibodies need to be used when evaluating acute leukemias by flow cytometry is controversial. Methods. Recent studies have suggested that antibodies against CD117 or c-kit are not essential for the assignment of blast lineage by flow cytometry, even though CD117 appears to be a very specific marker for myeloid lineage acute leukemias. We report a case of acute myeloid leukemia M2 subtype with an 8:21 translocation, where the leukemic blasts expressed CD117, CD19, and CD15 but did not show definitive expression of the myeloid markers CD13 or CD33. Results and Conclusions. This study highlights the importance of CD117 when evaluating acute leukemias by flow cytometry, which was necessary in this case to suggest that the blasts were phenotypically abnormal myeloblasts. In addition, this case presented an unusual acute myeloid leukemia phenotype that will likely be encountered by others and could be difficult to interpret. (C) 2003 Wiley-Liss, Inc.
引用
收藏
页码:40 / 43
页数:4
相关论文
共 50 条
  • [31] CD117 immunoreactivity in atypical fibroxanthoma
    Mathews, R. A.
    Schlauder, S. M.
    Calder, K.
    Morgan, M. B.
    LABORATORY INVESTIGATION, 2008, 88 : 98A - 98A
  • [32] CD117 expression in adenosquamous carcinoma
    Panse, Gauri
    McNiff, Jennifer M.
    Ko, Christine J.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (10) : 905 - 906
  • [33] CD117 in soft tissue sarcomas
    Barisella, M
    Andreola, S
    Rosai, J
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (03) : 470 - 471
  • [34] CD117 immunoreactivity in atypical fibroxanthoma
    Mathew, Rahel A.
    Schlauder, Scott M.
    Calder, Kenneth B.
    Morgan, Michael B.
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2008, 30 (01) : 34 - 36
  • [35] CD117 expression in glial tumors
    Cetin, N
    Dienel, G
    Gokden, M
    JOURNAL OF NEURO-ONCOLOGY, 2005, 75 (02) : 195 - 202
  • [36] NordiQC Assessments of CD117 Immunoassays
    Roge, Rasmus
    Bzorek, Michael
    Nielsen, Ole
    Vyberg, Mogens
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 87 - 91
  • [37] CD117 immunohistochemistry in sarcomatoid porocarcinoma
    Panse, Gauri
    Subtil, Antonio
    JOURNAL OF CUTANEOUS PATHOLOGY, 2017, 44 (06) : 596 - 598
  • [38] Expression of CD71 by flow cytometry in acute leukemias: More often seen in acute myeloid leukemia
    Pande, Amit
    Dorwal, Pranav
    Jain, Dharmendra
    Tyagi, Neetu
    Mehra, Simmi
    Sachdev, Ritesh
    Raina, Vimarsh
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2016, 59 (03) : 310 - 313
  • [39] Evaluation of the expression of C-kit (CD117) in ependymomas and oligodendrogliomas
    Zavalhia, Lisiane Silveira
    Romitti, Mirian
    Netto, Gabriel Corteze
    dos Santos, Giovana Tavares
    Meurer, Rosalva Thereza
    Hilbig, Arlete
    Michalowski, Mariana Bohns
    Ribeiro, Marlise de Castro
    DISEASE MARKERS, 2012, 33 (02) : 61 - 68
  • [40] A novel case of primary myelofibrosis with mastocytic differentiation; the characteristic CD117 vs HLA-DR dot plot on flow cytometry
    Panda, Devasis
    Pathak, Amardeep
    Tejwani, Narender
    Mehta, Anurag
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2023, 45 (04) : 613 - 615